SUPN Next Earnings Date Notes

— Supernus Pharmaceuticals (SUPN) is a biopharmaceutical company focused on developing & commercializing products for the treatment of central nervous system (CNS) disorders, such as epilepsy, Parkinson’s disease, and migraine. Its portfolio includes leading brands like Oxtellar XR, Trokendi XR, and Qelbree. For investors listening to the next earnings call, the most relevant business metrics to track include net product sales, especially for core CNS therapies, progress in pipeline development (notably late-stage clinical trials), and updates on regulatory submissions/approvals. Other key factors are gross margin and R&D spending, as these reflect operational efficiency & commitment to innovation. Pay close attention to management's outlook on prescription trends, as well as any guidance related to new product launches or label expansions. Additionally, licensing/development agreements and M&A activity could significantly impact long-term growth. These fundamental metrics & strategic updates will offer insights into Supernus’s ability to sustain revenue growth, expand its CNS franchise, and deliver value over time. The next projected earnings date for SUPN is 11/3/2026 after close (stay tuned for a confirmed earnings date once announced).

SUPN Next Earnings Date FAQ

On this page we presented the SUPN Next Earnings Date information for Supernus Pharmaceuticals along with recent past earnings dates. For Q2 of 2026, SUPN reported earnings of 0.530/share, with the earnings report taking place on 8/3/2026. For Q1 of 2026, SUPN reported earnings of -0.040/share, with the earnings report taking place on 5/5/2026. For Q4 of 2025, SUPN reported earnings of -0.070/share, with the earnings report taking place on 2/24/2026. For Q3 of 2025, SUPN reported earnings of -0.800/share, with the earnings report taking place on 11/4/2025. For Q2 of 2025, SUPN reported earnings of 0.400/share, with the earnings report taking place on 8/5/2025. Based on these past earnings dates, the projected next earnings date for SUPN is 11/3/2026 after market close.

Any self directed investor who desires to keep tabs on the companies they own, can benefit from maintaining a calendar of next earnings dates for each stock in their porfolio, such as Supernus Pharmaceuticals. When a company files its 10Q's with the SEC a mere four times a year, that certainly puts a lot of pressure on those four out of three hundred sixty five days! To say that earnings reports are important to Supernus Pharmaceuticals shareholders would thus be an understatement! That's why we started the NextEarningsDate.com website, to make it easy for self directed investors to research Supernus Pharmaceuticals next earnings dates as well as any other stock out there in our coverage universe, to see when the next SUPN earnings date — or any other stock — falls on the calendar. But we also present considerably more than just the next earnings date information alone, so we encourage you to explore the additional pages linked above to look up SUPN's past earnings as well, with pages for revenue and earnings history data, as well as earnings surprises as well. Thanks for visiting, and we hope you'll think of our site the next time you need to learn about the SUPN next earnings date.